Endonuclease activation and chromosomal DNA fragmentation during apoptosis in leukemia cells

International Journal of Hematology

Volumn 84, Issue 1, 2006, Pages 31-37

  Yoshida, Akira ^a   Pommier, Yves ^b   Ueda, Takanori ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AN34; Apoptosis; Apurinic apyrimidinic endonuclease 1 (Ape1); CAD DFF40; Endonuclease; Endonuclease G; Leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOTIC NUCLEASE 34; APURINIC APYRIMIDINIC ENDONUCLEASE 1; CASPASE 3; CASPASE ACTIVATED NUCLEASE; CASPASE-ACTIVATED DEOXYRIBONUCLEASE; DNA FRAGMENT; ENDONUCLEASE; ENDONUCLEASE G; FAS LIGAND; GENE PRODUCT; NUCLEASE; PROTEIN DFF40; PROTEIN DFF45; UNCLASSIFIED DRUG; APEX1 PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, MOUSE; CASPASE; CASPASE ACTIVATED DNASE INHIBITOR; CASPASE-ACTIVATED DNASE INHIBITOR; DEOXYRIBONUCLEASE; DFFB PROTEIN, HUMAN; DFFB PROTEIN, MOUSE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; SIGNAL PEPTIDE;

APOPTOSIS; CELL TYPE; CHROMATIN CONDENSATION; CHROMOSOME; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IONIZING RADIATION; LEUKEMIA CELL; MOUSE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CHROMATIN; GENE DELETION; GENETICS; LEUKEMIA; METABOLISM;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CASPASES; CHROMATIN; DEOXYRIBONUCLEASES; DNA FRAGMENTATION; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; ENZYME ACTIVATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA; MICE; SEQUENCE DELETION;

EID: 33748643234     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03342699     Document Type: Review

References (70)

1. Steller H. Mechanisms and genes of cellular suicide. Science. 1995; 267:1445-1449.
2. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell. 1997;88:347-354.
3. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
4. Walker PR, Sikorska M. New aspects of the mechanism of DNA fragmentation in apoptosis. Biochem Cell Biol. 1997;75:287-299.
5. Peitsch MC, Polzar B, Stephan H, et al. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis. (programmed cell death). EMBO J. 1993;12:371-377.
6. Rauch F, Polzar B, Stephan H, Zanotti S, Paddenberg R, Mannherz HG. Androgen ablation leads to an upregulation and intranuclear accumulation of deoxyribonuclease I in rat prostate epithelial cells paralleling their apoptotic elimination. J Cell Biol. 1997;137:909-923.
7. Gaido ML, Cidlowski JA. Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes: NUC18 is not histone H2B. J Biol Chem. 1991;266:18580-18585.
8. Krieser RJ, Eastman A. The cloning and expression of human deoxyribonuclease II: a possible role in apoptosis. J Biol Chem. 1998;273:30909-30914.
9. Barry MA, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys. 1993;300:440-450.
10. 2+-dependent endonuclease from human spleen: purification, properties, and role in apoptosis. Biochemistry. 1993;32:9129-9136.
11. Shiokawa D, Ohyama H, Yamada T, Tanuma S. Purification and properties of DNase gamma from apoptotic rat thymocytes. Biochem J. 1997;326(pt 3):675-681.
12. 2+-dependent endonuclease associated with apoptosis. J Immunol. 1996;156:922-931.
13. Pandey S, Walker PR, Sikorska M. Identification of a novel 97 kDa endonuclease capable of internucleosomal DNA cleavage. Biochemistry. 1997;36:711-720.
14. Bernardi G. Mechanism of action and structure of acid deoxyribonuclease. Adv Enzymol Relat Areas Mol Biol 1968;31:1-49.
15. Montague JW, Gaido ML, Frye C, Cidlowski JA. A calcium-dependent nuclease from apoptotic rat thymocytes is homologous with cyclophilin: recombinant cyclophilins A, B, and C have nuclease activity. J Biol Chem. 1994;269:18877-18880.
16. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;91:43-50.
17. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 2001;412:95-99.
18. 2+-dependent endonuclease (AN34) from etoposide-treated human leukemia HL-60 cells undergoing apoptosis. Cancer Res. 1998;58:2576-2582.
19. Yoshida A, Urasaki Y, Waltham M, et al. Human apurinic/apyrimidinic endonuclease (Ape1) and its N-terminal truncated form (AN34) are involved in DNA fragmentation during apoptosis. J Biol Chem. 2003; 278:37768-37776.
20. Walker PR, Smith C, Youdale T, Leblanc J, Whitfield JF, Sikorska M. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 1991;51:1078-1085.
21. Falcieri E, Martelli AM, Bareggi R, Cataldi A, Cocco L. The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in MOLT-4 cells without concomitant DNA fragmentation. Biochem Biophys Res Commun. 1993;193:19-25.
22. Oberhammer F, Wilson JW, Dive C, et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 1993;12:3679-3684.
23. Pandey S, Walker PR, Sikorska M. Separate pools of endonuclease activity are responsible for internucleosomal and high molecular mass DNA fragmentation during apoptosis. Biochem Cell Biol. 1994;72:625-629.
24. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J. 1992;286(pt 2):331-334.
25. Cohen GM, Sun XM, Fearnhead H, et al. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J Immunol. 1994;153:507-516.
26. Yoshida A, Ueda T, Wano Y, Nakamura T. DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells. Jpn J Cancer Res. 1993;84:566-573.
27. Yoshida A, Ueda T, Takauji R, et al. Role of calcium ion in induction of apoptosis by etoposide in human leukemia HL-60 cells. Biochem Biophys Res Commun. 1993;196:927-934.
28. Yoshida A, Takauji R, Inuzuka M, Ueda T, Nakamura T. Role of serine and ICE-like proteases in induction of apoptosis by etoposide in human leukemia HL-60 cells. Leukemia. 1996;10:821-824.
29. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res. 1994;211:314-321.
30. Qi SN, Yoshida A, Ueda T. Activation of caspases-3/7 is dispensable for idarubicin-induced apoptotic DNA fragmentation in human leukemia cells. Int J Oncol. 2003;22:1123-1128.
31. Solary E, Bertrand R, Pommier Y. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. Leuk Lymphoma. 1994;15:21-32.
32. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
33. Peitsch MC, Muller C, Tschopp J. DNA fragmentation during apoptosis is caused by frequent single-strand cuts. Nucleic Acids Res. 1993;21:4206-4209.
34. Walker PR, Leblanc J, Sikorska M. Evidence that DNA fragmentation in apoptosis is initiated and propagated by single-strand breaks. Cell Death Differ. 1997;4:506-515.
35. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 1997;89:175-184.
36. Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L, Williams LT. CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr Biol. 1998;8:537-540.
37. Liu X, Li R Widlak P, et al. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA. 1998;95:8461-8466.
38. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 1998;391:96-99.
39. Mukae N, Enari M, Sakahira H, et al. Molecular cloning and characterization of human caspase-activated DNase. Proc Natl Acad Sci U S A. 1998;95:9123-9128.
40. Kawane K, Fukuyama H, Adachi M, et al. Structure and promoter analysis of murine CAD and ICAD genes. Cell Death Differ. 1999; 6:745-752.
41. Gu J, Dong RP, Zhang C, McLaughlin DF, Wu MX, Schlossman SF. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40. J Biol Chem. 1999;274:20759-20762.
42. Zhang J, Liu X, Scherer DC, van Kaer L, Wang X, Xu M. Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. Proc Natl Acad Sci U S A. 1998; 95:12480-12485.
43. Yuste VJ, Bayascas JR, Llecha N, Sanchez-Lopez I, Boix J, Comella JX. The absence of oligonucleosomal DNA fragmentation during apoptosis of IMR-5 neuroblastoma cells: disappearance of the caspase-activated DNase. J Biol Chem. 2001;276:22323-22331.
44. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 1989;49:5870-5878.
45. Saeki K, Yuo A, Kato M, Miyazono K, Yazaki Y, Takaku F. Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor β1 and overexpression of Bcl-2. J Biol Chem. 1997;272:20003-20010.
46. Martin SJ, Lennon SV, Bonham AM, Cotter TG. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol. 1990;145:1859-1867.
47. Robson CN, Hickson ID. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res. 1991;19:5519-5523.
48. Xanthoudakis S, Miao G, Wang F, Pan YC, Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 1992;11:3323-3335.
49. Seki S, Akiyama K, Watanabe S, Hatsushika M, Ikeda S, Tsutsui K. cDNA and deduced amino acid sequence of a mouse DNA repair enzyme (APEX nuclease) with significant homology to Escherichia coli exonuclease III. J Biol Chem. 1991;266:20797-20802.
50. Barzilay G, Hickson ID. Structure and function of apurinic/apyrimidinic endonucleases. Bioessays. 1995;17:713-719.
51. Yoshida A, Ueda T. Human AP endonuclease possesses a significant activity as major 3′-5′ exonuclease in human leukemia cells. Biochem Biophys Res Commun. 2003;310:522-528.
52. Gorman MA, Morera S, Rothwell DG, et al. The crystal structure of the human DNA repair endonuclease HAP1 suggests the recognition of extra-helical deoxyribose at DNA abasic sites. EMBO J. 1997;16:6548-6558.
53. Xanthoudakis S, Smeyne RJ, Wallace JD, Curran T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc Natl Acad Sci U S A. 1996;93:8919-8923.
54. Demple B, Herman T, Chen DS. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Natl Acad Sci U S A. 1991;88:11450-11454.
55. Chaudhry MA, Dedon PC, Wilson DM 3rd, Demple B, Weinfeld M. Removal by human apurinic/apyrimidinic endonuclease 1 (Ape 1) and Escherichia coli exonuclease III of 3′-phosphoglycolates from DNA treated with neocarzinostatin, calicheamicin, and γ-radiation. Biochem Pharmacol. 1999;57:531-538.
56. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 1997;11:558-570.
57. Walker LJ, Robson CN, Black E, Gillespie D, Hickson ID. Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding. Mol Cell Biol. 1993;13:5370-5376.
58. Xanthoudakis S, Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J. 1992;11:653-665.
59. Gaiddon C, Moorthy NC, Prives C. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J. 1999;18:5609-5621.
60. Hall JL, Wang X, Van A, Zhao Y, Gibbons GH. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-KB-independent and -dependent pathways. Circ Res. 2001;88:1247-1253.
61. Wright SC, Wei QS, Zhong J, Zheng H, Kinder DH, Larrick JW. Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J Exp Med. 1994;180:2113-2123.
62. Wright SC, Schellenberger U, Wang H, Kinder DH, Talhouk JW, Larrick JW. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J Exp Med. 1997; 186:1107-1117.
63. Shimizu T, Pommier Y. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases. Leukemia. 1997;11:1238-1244.
64. Cote J, Ruiz-Carrillo A. Primers for mitochondrial DNA replication generated by endonuclease G. Science. 1993;261:765-769.
65. Braun T, Carvalho G, Coquelle A, et al. NF-κB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. Blood. 2006;107:1156-1165.
66. Saumet A, Slimane MB, Lanotte M, Lawler J, Dubernard V. Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/αvβ3 in promyelocytic leukemia NB4 cells. Blood. 2005;106:658-667.
67. McKenna SL, Hoy T, Holmes JA, Whittaker JA, Jackson H, Padua RA. Flow cytometric apoptosis assays indicate different types of endonuclease activity in haematopoietic cells and suggest a cautionary approach to their quantitative use. Cytometry. 1998;31:130-136.
68. Iguchi K, Hirano K, Ishida R. Activation of caspase-3, proteolytic cleavage of DFF and no oligonucleosomal DNA fragmentation in apoptotic Molt-4 cells. J Biochem (Tokyo). 2002;31:469-475.
69. Kawabata Y, Hirokawa M, Kitabayashi A, Horiuchi T, Kuroki J, Miura AB. Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: a novel mechanism of nuclear apoptosis resistance. Blood. 1999;94:3523-3530.
70. McConkey DJ, Chandra J, Wright S, et al. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol. 1996;156:2624-2630.